Serum LIGHT has been reported as a potential biomarker of inflammatory diseases, such as rheumatid arthritis, ankylosing spondylarthritis, inflammatory bowel disease, and atopic dermatitis [16–19], but its association with the pathogenesis of DM-IP has not been clarified. This evidence concerns the gene TNFSF14 and dermatomyositis.